Sun Pharma initiates trial for deuruxolitinib in severe alopecia areata in Japan
A clinical trial is underway to assess deuruxolitinib's efficacy and safety in Japanese adults with severe alopecia areata.
Therapeutic Area
Therapeutic area intelligence for Alopecia Areata with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.